author-photo

Olga Oikonomidou

University of Edinburgh

21

Papers

120

Citations

Citation Trend

Filter By

Papers (16) Sort By

Journal Conference Others

Lobular Breast Cancer: A Review

2021 Frontiers in Oncology
Show All
- Source
- Cite
- Save
Citations (3)
Expert Discussion: HER2-Positive Breast Cancer.

2021 Breast Care
Show All
- Source
- Cite
- Save
Citations (0)
Abstract P1-01-03: Association of cardiac energetics and plasma biomarkers with anthracycline-based chemotherapy in breast cancer patients

2020 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Circulating tumour DNA analysis to direct therapy in advanced breast cancer (plasmaMATCH): a multicentre, multicohort, phase 2a, platform trial.

2020 Lancet Oncology
Show All
- Source
- Cite
- Save
Citations (57)
Early Triple Negative Breast Cancer: Conventional Treatment and Emerging Therapeutic Landscapes.

2020 Cancers
Show All
- Source
- Cite
- Save
Citations (26)
Risk of chemotherapy-related amenorrhoea (CRA) in premenopausal women undergoing chemotherapy for early stage breast cancer.

2020 Breast Cancer Research and Treatment
Show All
- Source
- Cite
- Save
Citations (0)
Abstract P1-19-04: Results from plasmaMATCH trial treatment cohort A: A phase II trial of extended-dose fulvestrant in patients with an ESR1 mutation identified via ctDNA screening (CRUK/15/010)

2020 Cancer Research
Show All
- Source
- Cite
- Save
Citations (2)
Abstract P1-19-14: Results from plasmaMATCH trial treatment cohort D: A phase II trial of capivasertib in patients with an AKT activation basket mutation identified via ctDNA testing or tumour sequencing (CRUK/15/010)

2020 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Cardiac Energetics Before, During and After Anthracycline-based Chemotherapy in Breast Cancer Patients Using 31P Magnetic Resonance Spectroscopy: A Pilot Study

2020
Show All
- Source
- Cite
- Save
Citations (0)
Abstract P6-16-04: IL6ST, a biomarker of endocrine therapy response, has potential in identifying a subgroup of women with ER+ DCIS who are more likely to benefit from adjuvant endocrine therapy

2020 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)